Testosterone undecanoate - Organon

Drug Profile

Testosterone undecanoate - Organon

Alternative Names: Andriol; Androxon; Panteston; Restandol; Undestor; Virigen

Latest Information Update: 13 Feb 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Organon
  • Class Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Hypogonadism

Most Recent Events

  • 05 Feb 2014 MSD Korea and Hanmi Pharmaceutical agree to co-promote testosterone undecanoate in South Korea for Hypogonadism
  • 19 Nov 2007 Organon has been acquired and merged into Schering-Plough
  • 15 Nov 1999 A modified form of Andriol® is undergoing phase III trials in the US and Europe
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top